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Background: The fallopian tube transports the gametes to the fertilization site and delivers the embryo to the
uterus at the optimal time for implantation. Progesterone and the classical progesterone receptor are involved in
regulating both tubal ciliary beating and muscular contractions, likely via both genomic and non-genomic actions.
Methods: To provide more details of the underlying mechanisms, we investigated the effect of progesterone on
gene expression in mice fallopian tubes in vitro at 20 min, 2 h and 8 h post progesterone treatment using
microarray and/or quantitative PCR. In parallel, oocyte cumulus complex transport was investigated in ovulating
mice that were injected with one of the progesterone receptor antagonists, Org 31710 or CDB2194.
Results: Microarray analyses did not reveal any apparently regulated genes 20 min after progesterone treatment,
consistent with the proposed non-genomic action of progesterone controlling ciliary beating. After 2 h, 11 genes
were identified as up-regulated. Analyses using quantitative PCR at 2 h and 8 h showed a consistent up-regulation
of endothelin1 and a down-regulation of its receptor Endothelin receptor A by progesterone. We also confirmed
that treatment with progesterone receptor antagonists before ovulation accelerates the transport of the oocyte
cumulus complex.
Conclusions: This is the first study showing that progesterone regulates the expression of endothelin1 and
endothelin receptor A in the fallopian tube. Together with previous studies of the effects of endothelin on
muscular contractions in the fallopian tube, the results from this study suggest that endothelin is a mediator
of the progesterone-controlled effects on muscular contraction and eventually gamete transport in the fallopian
tube.
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The fundamental steps in female reproduction include the
transport of the oocyte cumulus complex (OCC) from the
site of ovulation to the site of fertilization and further
transport of the fertilized embryo to the site of implant-
ation. The fallopian tube provides the ways and means of
this process by muscular contraction, ciliary movement
and flow of secretions [1], which are influenced and
affected by progesterone and the classical progesterone re-
ceptor (PGR) [2–4]. The roles of progesterone in the* Correspondence: joakim.larsson@fysiologi.gu.se
1Department of Infectious Diseases, Institute of Biomedicine, The Sahlgrenska
Academy, University of Gothenburg, Guldhedsgatan 10, SE–413 46
Gothenburg, Sweden
Full list of author information is available at the end of the article
© 2015 Bylander et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.ovary, uterus and mammary gland have been well de-
scribed, but its role and detailed mode of action in the fal-
lopian tube are not as well defined. Overall, progesterone
affects processes that influence and optimize the transport
of the OCC to the site of fertilization as well as nourish
and transport the embryo to the uterus. Because proges-
terone acts to increase the chance of a successful implant-
ation, it is important to also reveal the mechanisms
behind its actions in the fallopian tube [5–8].
Progesterone is involved in the regulation of the fre-
quency of muscle contractions in human fallopian tubes
in vitro in a dose-dependent manner [9]. The regulation
of muscle contractions is complex and influenced by
several factors, such as sex steroids, prostaglandins andal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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traction, and progesterone promotes relaxation [10, 15].
Prostaglandins seem to have a dual effect on contractility
where the E-series (PGE) relaxes muscle activity and the
F-series (PGF) induces muscle activity. This response ap-
pears to be influenced by ovarian steroids, as progesterone
increases the response to PGE1 and decreases the response
to PGF2alpha [16]. Research have shown that the expres-
sion of PGE and PGF2alpha receptors are affected by mife-
pristone (RU486), an antagonist to both corticoid and
progesterone receptors, suggesting that prostaglandin re-
ceptors in the fallopian tube are directly or indirectly regu-
lated by progesterone [17]. The role of endothelins in the
fallopian tube is relatively well established. Both endothe-
lin 1 (EDN1) and endothelin 2 (EDN2) have been shown
to increase muscular contractility in the fallopian tube
[11–13]. One in vitro study by Wanggren et al. demon-
strated the effects of 100 nM progesterone on muscle con-
tractions in the fallopian tube within 20 min [9]. Such a
rapid time course supports the hypothesis that progester-
one regulates muscular activity through both transcrip-
tional and non-transcriptional pathways. In the study by
Wanggren, the effect of progesterone was not blocked by
the antagonist mifepristone (RU486), which could indicate
the involvement of a receptor other than the PGR. How-
ever, progesterone and RU486 was administered at the
same time and at equal concentrations, which may not be
sufficient for efficient blockage [18, 19].
The exact location of the PGR in the fallopian tube is
under debate. Immunohistochemistry data suggest a lo-
cation in the lower half of the cilia in both mouse and
human fallopian tubes [20]. Another study suggests a
PGR location in the nuclear compartments of the lu-
minal, epithelial and smooth muscle cells in the mouse
fallopian tube [21]. In addition to the PGR, there are
several candidate receptors that could potentially medi-
ate the non-transcriptional effects of progesterone, in-
cluding the membrane progesterone receptors (mPRs)
[22]. Two isoforms of mPRs are present in the fallopian
tube in both humans and mice, and both isoforms are
regulated by progesterone [23, 24].
It is now well documented that progesterone decreases
the ciliary beat frequency (CBF) of the fallopian tube. In
humans, a high concentration of progesterone (10 μmol/L)
reduced the CBF by 40–50 % 24 h after exposure [2].
In a similar study on ciliary cells from bovine oviduct,
20 μmol/L progesterone caused a reduction in the CBF
within 30 min after exposure [19]. Studies in our labora-
tory on ciliary cells from mice have demonstrated an even
faster (10–20 min) significant reduction of CBF by proges-
terone, using physiologically relevant concentrations of
progesterone in the range of 10–100 nmol/L [4, 18]. We
have previously established the involvement of the clas-
sical PGR in these rapid effects of progesterone on CBF.The reduction in CBF was induced when ciliary cells
were exposed both to progesterone and promegestone, a
specific agonist to PGR, and the reduction in CBF was
blocked when ciliary cells were pre-treated with excess
RU486 before exposure to progesterone. In mice lacking
a functional Pgr, there was no reduction in CBF after pro-
gesterone administration [18]. Taken together, these find-
ings indicate that PGR mediate the rapid CBF response to
progesterone in the fallopian tube. The rapid effects sug-
gest a non-genomic response may be involved, but data
on the potential rapid changes in gene transcription in the
fallopian tube following progesterone treatment are not
known.
Studies have also suggested that PGR directly affects
OCC and embryo transport of the fallopian tube in vivo.
In one study, rats were treated with RU486 from the day
of ovulation after which the fallopian tubes and uteri
were flushed at different time points. In rats treated with
RU486, the eggs arrived approximately 11 h earlier to the
uterus than in the control rats. In another study, mice
were administered a daily subcutaneous injection of two
different progesterone receptor antagonists, RU486 and
ZK98734, or vehicle during the 3 first days of pregnancy,
and the uteri were flushed on the afternoon of day 3. Both
antagonists significantly increased the number of embryos
in the uterus compared to the control i.e., stimulated pre-
mature entry to the uterus [25, 26].
We hypothesize that PGR-mediated gene expression in
the fallopian tube is part of the short and/or long-term
regulation of OCC transport. We have started to address
this by investigating global gene expression in the mouse
fallopian tube after progesterone treatment in vitro to
exclude indirect effects mediated by modulating the se-
cretion of other hormones within the hypothalamus-
pituitary-gonadal axis. The timing of regulation as well as
the identity of these genes could provide insight into the
mechanisms of progesterone-regulated OCC transport.
Furthermore, the functional role of progesterone and PGR
in the transport of the OCC in the fallopian tube was con-
firmed. The distribution of the PGR in the mouse fallopian
tube was also investigated.
Methods
Animals
All animal experiments were approved by the local ani-
mal ethics committee in Gothenburg, Sweden, (50/2011)
to DGJL and (58/2007) to RS. The mice used in this
study were all immature female (3.5–5 weeks old)
C57BL/6 N mice from Charles River, Kisslegg, Germany.
The animals were housed under a 12:12 h light-dark
schedule at 21 °C ± 2 °C with unlimited access to food
and water. Before the start of experiment, the animals
were allowed to acclimate to the animal facilities for ≥
5 days.
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assessment of OCC transport
To investigate the role of PGR in OCC transport, ovulation
was stimulated in 105 immature mice by intraperitoneal
injection (i.p) of 5 IU Pregnant mare's serum gonadotropin
(PMSG) (N .V. Organon, Oss, Holland) followed 48 h later
by i.p injection of 5 IU of human chorionic gonadotropin
(hCG) (N.V. Organon, Oss, Holland). In rodents, ovula-
tion occurs 12–14 h after PMSG/hCG treatment. To de-
termine whether a single dose of a PGR antagonist
influences ovum transport, 40 of the PMSG/hCG-treated
mice received an i.p. injection of Org31710 (8 μg/g) 6 h
after the hCG injection, 25 were instead treated with an-
other more specific PGR antagonist CDB2194 (8 μg/g)
[27–29], whereas 40 control mice were administered hu-
man chorionic gonadotropin vehicle only. The time point
for the antagonist injection was chosen because we
wanted to administer the antagonist before the OCCs
were released into the fallopian tube but not too early to
risk blocking the ovulation process. Both antagonists were
dissolved in ethanol and suspended in sesame oil, whereas
control mice were administered ethanol and sesame oil
only (i.p. injection volume 100 μl). Both Org31710 and
CDB2194 are more potent and show less anti glucocortic-
oid activity than other PGR antagonists such as RU486
and ZK 98299 [30]. We use two antagonists to show with
higher certainty that the effect is indeed through the PGR.
The doses of Org31710 and CDB2194 were chosen based
on previous studies [28, 30]. All drug solutions were
freshly prepared before each experiment. Mice from each
treatment group were killed by cervical dislocation, and
their fallopian tubes were removed, dissected and exam-
ined under a dissecting microscope at 24, 27, 30, 36, and
48 h after hCG injection. The presence of OCCs in the fal-
lopian tubes were determined by flushing the fallopian
tubes and observing if any OCCs were retrieved under the
microscope. Please note that the females were kept in
cages without males, and thus, there were no fertilized
eggs present.
Tissue collection and progesterone exposure in vitro
Immature female mice (not treated with any hormones)
were anesthetized by inhalation of isoflourane and then
killed by inhalation of carbon dioxide followed by dissec-
tion. Both fallopian tubes were immediately removed
and washed in pre-warmed (37 °C) G-MOPS™ (Vitrolife,
Gothenburg, Sweden). G-MOPS is a medium specially
developed for handling and manipulation of oocytes and
embryos under normal air. After the removal of the
broad ligaments, fat and blood vessels, the whole fallo-
pian tubes, including all segments (total length approxi-
mately 18 mm) were longitudinally opened, cut into
smaller pieces and then transferred to a new petri dish
containing 2 ml pre-warmed G-MOPS™. In fallopiantubes from mice in this stage of development, ciliary
cells and secretory cells are clearly visible [23]. Proges-
terone (>99 % purity, Sigma-Aldrich, St Louis, MO) was
first dissolved in ethanol and then further dissolved in
G-MOPS™. To add progesterone to the fallopian tubes,
half of the medium in the petri dish was removed and
replaced with an equal amount of medium containing
progesterone and ethanol resulting in a final concentra-
tion of 100 nmol/L progesterone and 0.01 % (v/v) ethanol.
The fallopian tubes in the control samples were exposed
to ethanol (0.01 % (v/v)) only. The concentration of pro-
gesterone was based on results from our previous studies
demonstrating clear effects on ciliary motility in this
in vitro model [4, 18]. From each mouse, one fallopian
tube was exposed to progesterone and one was used as
the control. A total number of 48 mice and 96 fallopian
tubes were used. The tissue samples were exposed for
20 min or 2 h, and immediately after exposure, they were
snap-frozen in liquid nitrogen and stored at −80 °C until
RNA extraction. To obtain sufficient quantities of RNA
for the microarray analyses, six fallopian tubes (three ani-
mals) were pooled in one petri dish to form one sample.
For each time point, we had four sample pairs resulting in
a total of 16 samples. For additional gene expression ana-
lysis with quantitative PCR (qPCR), the fallopian tubes
from an additional 36 mice were exposed to 100 nmol/L
progesterone or control medium for 2 h or 8 h, resulting
in four groups. For this analysis, less RNA was required,
and the fallopian tube tissue from one mouse was suffi-
cient to analyze as an independent sample. Thus, in total,
nine samples from nine separate mice from each treat-
ment group were analysed using qPCR. Immediately after
exposure, the samples were snap−frozen in liquid nitrogen
and stored at −80 °C.
RNA extraction and gene expression analysis
Fallopian tube samples were removed from liquid nitrogen
storage and homogenized using a Tissue Lyser (Qiagen,
Hilden, Germany). Total RNA was extracted using the
RNeasy Plus micro Kit (Qiagen) according to the manufac-
turer’s protocol. RNA quality and quantity were evaluated
based on spectrophotometric measurements (Nanodrop
1000, NanoDrop Technologies, USA) and possible RNA
degradation was measured with an RNA StdSens ana-
lysis kit and Experion (Experion™ Electrophoresis Station,
Bio-Rad laboratories, Hercules, CA).
Microarray analyses
The gene expression in the fallopian tube after exposure
to progesterone for 20 min or 2 h was analysed by
microarray performed at the Swegene Centre for Inte-
grative Biology (SCIBLU) at Lunds University, Lund,
Sweden. In short, 500 ng total RNA was processed using
the Illumina®Totalprep-96RNA Amplification kit 4397949
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tions to generate double stranded cDNA. The cDNA was
used as a template to produce biotin-labeled cRNA ac-
cording to the manufacturer’s specifications. The cRNA
was then hybridized on to MouseRef-8 v2 Expression
BeadChip using Whole-Genome Gene Expression Direct
Hybridization Assay (Illumina) following the manufac-
turer’s instructions. The Beadchips were scanned in the
iScan system using the Standard Illumina iScan N240
scanning protocol. Experimental quality analyses, probe
summarization and quantile normalization [31] were per-
formed using the GenomeStudio software V2011.1. Probe
sets without signal intensity, i.e., intensity above the me-
dian of negative control intensity signals, in 80 % of the
samples were excluded. Probe sets with no gene annota-
tions or expired annotations were filtered. A paired (four
sample pairs exposed for 20 min and four sample pairs ex-
posed for 2 h) Significance Analysis of Microarrays (SAM)
[32] was preformed to identify differently expressed genes
between the groups using the TMEV v4.0 software [33].
For each gene, a q-value was reported. The q-value is
similar to the more well-known p-value but adapted to
multiple testing situations. Genes with a q-value ≤20 were
considered differentially expressed. Data from the micro-
array experiment is available with accession number
GSE61407 at the NCBI Gene Expression Omnibus public
repository (GEO) according to MIAME guidelines. The
time point of 20 min was chosen to be able to identify
possible genes involved in regulating the rapid reduc-
tion in CBF observed in our previous papers within
that time period. We choose two hours as our second
time point because we had previously established that the
ciliary activity remains stable for at least two h of incuba-
tion [4, 18].
Quantitative PCR
Four genes (Edn1, Amigo2, Arlf4 and Rasd1) that tended
to be differentially expressed after 2 h of progesterone
exposure, as measured by the microarray analysis, were
further assessed with quantitative PCR analysis. The
genes were selected based on their fold change and a
connection to progesterone or PGR in the literature.
However, no PCR products were obtained for Arlf4 (data
not shown). The gene expression of five additional genes
(Pgr, Edn2, Edn3, Ednra, Ednrb) was also assessed. These
genes were not regulated according to the microarray
but were selected based on a potential role in gamete
transport. The analysis was performed on new samples
from 36 mouse fallopian tubes exposed to progesterone
(or control) for 2 h or 8 h in vitro. From each sample
1 μg of RNA was reverse-transcribed with a mixture of
random hexamers and oligo (dt) primers, using the
iScript cDNA Synthesis Kit (Bio-Rad). cDNA synthesis
was performed according to the manufacturer’s protocol.The template cDNA, TaqMan Gene Expression master
mix and pre-formulated primers and probes purchased
as TaqMan Gene Expression assays (Life Technologies)
were mixed and run in accordance with the manufac-
turer’s instructions. Taqman assay-identities are presented
in Additional file 1: Table S1. Amplification reactions were
carried out in triplicate with and started with a 10 min
denaturation step at 95 °C followed by 40 cycles of
15 s at 95 °C and 1 minute at 60 °C. All amplification
reactions were carried out in 385-well plates using
the QuantStudio 12 K Flex (Applied Biosystems/Life
Technologies; Stockholm, Sweden) and analysed with
QuantStudio software. Technical replicates that evidently
differed from the others were excluded from further ana-
lysis. The qPCR results were analysed by normalizing the
median CT value of the three technical replicates with the
average of the median CT values from two reference genes,
and the resulting ΔCT values were used for statistical ana-
lyses. Rpl19 and Hprt1 were used as housekeeping genes,
both of which had stable mRNA expression levels in all
samples and between groups (2 h p = 0.91, 8 h p = 0.55
and 2 h p = 0.91, 8 h p = 0.91, respectively) (two-sided stu-
dent’s t-test).LacZ staining
To identify cells that express the PGR, we used fallopian
tubes from PgrLacZ (+/−) mice. The LacZ mice were
adult females who were kept without males, and we did
not assess the stage of the cycle at the time of sampling.
The fallopian tubes were dissected out and cleaned be-
fore they were frozen in OTC medium (Tissue-Tek
O.T.C. Sakura Finetek Europe B.V). Then, they were cut
into pieces (5–10 μM) in a cryostat (Leica CM3050S,
Leica Microsystems AB) and placed on glass slides. To
determine the β-galactosidase activity in the tissue we
used a LacZ staining kit (InvivoGen, San Diego, USA).
The glass slides were prepared according to the manu-
facturer’s protocol. In cells expressing the LacZ gene,
β-galactosidase catalyzes the hydrolysis of X-Gal, pro-
ducing a blue precipitate that can be visualized under
a microscope.Statistical analyses
The statistical analysis was calculated based on the pro-
portion of mice with at least one OCC present in the fal-
lopian tube, not on the number of OCCs found in the
fallopian tube. Fisher´s exact test were used to test if the
ratios of mice with OCCs in the fallopian tube differed
between mice given vehicle or either of the antagonists.
Tests for differential gene expression (qPCR) between
control and progesterone-exposed fallopian tubes were
performed using two-sided student’s t-test with 0.05 as
the alpha-value.
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Table 1 presents the percent of mice with OCC present
in the fallopian tube after treatment with two PGR an-
tagonists or vehicle at different time points. In mice
treated with Org 31710, a significant decrease in the ra-
tio of mice with OCC present in the fallopian tube was
found both at 30 h (p = 0.007) and 36 h (p = 0.0256) after
hCG treatment. For mice treated with CDB2194, a simi-
lar significant decrease in the ratio of mice with OCC
present was found at 27 h (p = 0.007) and 30 h (p =
0.0008) after hCG injection. At the doses given, there
were no significant differences at any time point between
the effects of the two antagonists. These results are con-
sistent with the hypothesis that blockage of the PGR ac-
celerates OCC transport.
To identify possible progesterone-dependent genes in-
volved in gamete transport and in rapid reduction of CBF,
we performed a microarray analysis on fallopian tubes iso-
lated from mice and exposed in vitro to 100 nmol/L pro-
gesterone for 20 min and 2 h. Exposure to progesterone
for 20 min did not induce any significant change in gene
expression in the mouse fallopian tube as assessed by the
microarray analysis.
Table 2 provides a list of 11 genes that were differently
expressed in mouse fallopian tubes after exposure to
progesterone for 2 h compared to control fallopian
tubes. Nine of these genes (Arlf4, Rasd1, Edn1, Irak2,
Amigo2, Cxcl1, Edn1, P4ha2 and Serpina3n) produce a
gene product that is involved in signalling processes. The
progesterone induced gene expression changes of three of
these genes (Edn1, Amigo2 and Rasd1) were confirmed
with qPCR analysis (Fig. 1). The mRNA abundance of
Amigo2 was significantly higher after 2 and 8 h of expos-
ure to progesterone (p <0.0001 for both time points,
respectively) compared to the controls. The mRNA levels
of Rasd1 (p <0.0001 for both time points) and Edn1
(p = 0.043 and p = 0.012) were also significantly increased
at both time points. EDN1 is known to be involved in
muscular contraction of the human and bovine fallopian
tube [12–14], and thus, the two other isoforms of
endothelin (Edn2 and Edn3) and its receptors (Ednra
and Ednrb) were included in the analysis even thoughTable 1 Progesterone receptor antagonists accelerate the transport
Percent of Mice with OCCs in the Fallopia
Hours after hCG Treatment
Treatment 24 27
Vehicle 75 (8) 100 (8)
Org 31710 (8 μg/g) 100 (8) 62.5 (8)
CDB2194 (8 μg/g) 100 (5) 20 (5)*
Total number of mice in each group is given in parenthesis. Vehicle or antagonist (
chorionic gonadotropin (hCG). At each sampling point, Fisher’s exact test was used
between mice administered vehicle or either antagonist. The time points where the
indicated by an asterisk.they were not identified as regulated by the microarray.
We also included Pgr in the analysis because earlier studies
have shown a regulation by progesterone in the fallopian
tube [21]. Ednra (p = 0.01 and p = 0.004, 2 h and 8 h, re-
spectively) and Pgr (p = 0.004 and p <0.0001) had a lower
mRNA abundance after progesterone exposure, whereas
there was no significant treatment effect for Edn2 (p = 0.63
and 0.10) and Edn3 (p = 0.25 and 0.29).
To investigate the location of PGR in the mouse fallo-
pian tube, we used fallopian tubes from PGRLacZ mice
and a staining kit to detect β-galactosidase activity. As
shown in Fig. 2, positive staining was observed in both
epithelial and muscle cells.
Discussion
Previous studies reporting the localization of PGR in the
fallopian tube has been based on immunostaining [20, 21].
Here, we applied a method that does not depend on
the specificity of antibodies. The results show that a sub-
population of both epithelial cells and stromal cells ex-
press the PGR. This is consistent with the hypothesis that
progesterone regulates both ciliary activity and muscle
contractions via the PGR.
We also show that a single dose of two different PGR
antagonists causes a rapid disappearance of the OCCs in
the mouse fallopian tube. This is consistent with earlier
studies showing that in rats and mice treated continu-
ously with antagonists for PGR, the embryos arrived pre-
maturely to the uterus [25, 26].
In a previous study from our laboratory, we showed
that the rapid reduction of CBF, which was manifested
within 20 min after progesterone administration, was
inhibited if the ciliary cells were pre-treated with RU486
and in ciliary cells from mice lacking a functional Pgr
[18]. This shows that PGR is most likely involved in this
rapid regulation of the CBF. Combining these data with
the effect of progesterone antagonists on OCC transport
in vivo further indicates an important role of progester-
one and the classical nuclear progesterone receptor in
this process, which is at least partly mediated by changes
in ciliary activity. In this study, we were not able to iden-
tify any changes in transcription abundance 20 min afterof the oocyte cumulus complex (OCC) in mouse fallopian tube
n Tube (number)
30 36 48
100 (8) 62.5 (8) 0 (8)
25 (8)* 0 (8)* 0 (8)
0 (5)* 0 (5) 0 (5)
Org 31710 or CDB2194) were administered 6 h after an injection with human
to calculate if the ratio of mice with OCC present in the fallopian tube differed
number of mice with OCC is significantly different from the vehicle group are
Table 2 Genes regulated by progesterone after 2 h in mouse fallopian tubes
Gene symbol Gene name Selected GO-terms (Biological Process) Fold-change
Serpina3n Serpin Peptidase Inhibitor, Clade A, member 3 Response to peptide hormone 1.4
Edn1 Endothelin-1 Intracellular signaling cascade, Maternal process involved in
parturition, Positive regulation of smooth muscle contraction
1.3
Rasd1 RAS, dexamethasone-induced 1 Intracellular signaling cascade, nitric oxide mediated signal
transduction, small GTPase mediated signal transduction
1.4
Slc25a33 Solute carrier family 25 member 33 Small molecule transport 1.6
Tigd2 Tigger transposable element-derived protein 2 DNA binding 1.9
Arfl4 ADP-ribosylation factor like 4D Intracellular signaling cascade 1.9
Irak2 Interleukin-1 receptor associated kinase 2 Intracellular signaling cascade 1.3
Cxcl1 chemokine (C-X-C motif) ligand 1 Positive regulation of cytosolic calcium ion concentration 1.4
Glrx Glutaredoxin AtPase binding 1.9
Amigo2 Adhesion molecule with ig like domain 2 Cell adhesion, negative regulation of programmed cell death 1.3
P4HA2 Prolyl 4 hydroxylase alpha polypeptide II Oxidation-reduction process 1.3
Mice fallopian tubes were treated in vitro with progesterone (100 nmol/L) or vehicle for 2 h and analysed by microarray. Eleven genes were differentially expressed
(q-value ≤20 %). The fold-change refers to progesterone versus vehicle-treated fallopian tubes. A positive value indicates up-regulation by progesterone.
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whether there are genes regulated after 20 min of pro-
gesterone exposure that were not discovered with the
microarray analyses, our finding is consistent with the
hypothesis that PGR regulates ciliary function in the fal-
lopian tube via a non-genomic mechanism. Experiments
with blockers of transcription or translation may provide
more evidence for this hypothesis.
Transcriptional effects by progesterone were detectable
after 2 h, as measured by microarray and qPCR. Nine of
the genes that tended to be differentially expressed
(Arlf4, Rasd1, Edn1, Irak2, Amigo2, Cxcl1, Edn1, P4ha2
and Serpina3n) produce gene products that are involved
in different signalling processes, and some of the genes
are regulated by progesterone and Pgr in different cell
lines in other studies [34–40]. Amigo2 plays a role in cell-
adhesion and cell migration. Rasd1 encodes for a protein
that is an activator of G-protein signalling. This gene is
thought to be involved in nitric oxide signal transduction,
which in the fallopian tube has been shown to affect
muscle contractility [41, 42].
Most interestingly, Edn1 was differentially expressed,
both after 2 and 8 h of progesterone exposure. The ab-
sence of apparent regulation at 20 min suggests that
progesterone-activation of the endothelin system via
gene transcription is not a prerequisite for regulating cil-
iary function, but its regulation at later time points in
the fallopian tube suggests that the endothelin system
could be involved in other processes related to gamete
transport. Indeed, EDN1 is known to induce muscle
contractility in the fallopian tube [11, 12, 43]. Earlier stud-
ies show that estrogen and estrogen in combination with
progesterone and luteinizing hormone significantly stimu-
lates the production and secretion of EDN1 from bovine
oviduct epithelial cells in culture. However, progesteronealone at concentrations ranging from 30 nmol/L to
3 μmol/L caused no significant increase in either produc-
tion or secretion of EDN1 [44, 45]. In the present study
progesterone induced the expression of the Edn1 gene
while causing a down-regulation of its receptor, Ednra. The
reason for these somewhat contradictory results between
the studies might be related to the fact that they are per-
formed in different species using different methodologies.
We measured the mRNA abundance in fallopian tubes
from immature mice, after in vitro progesterone exposure.
The other study measured the cell content and secretion of
EDN1 from cultured oviductal epithelial cells from cows
sampled during the estrous cycle. Consistent with our
results, it has been previously demonstrated that Edn1 is
induced by Pgr-A in mouse granulosa cell culture [46].
EDN1 binds to two receptors EDNRA and EDNRB,
with equal affinity, but the majority of its effect is medi-
ated through EDNRA [47]. The localization of EDN1
within the human fallopian tube is suggested to be
mainly within the tubal epithelium but also to a lesser
extent in the muscle layer, while EDNRA is suggested to
be dominant in the muscle layer [48]. The Edn1, Edn2
and Edn3 as well as the Ednra and Ednrb genes are re-
ported to be expressed in bovine and mice oviducts during
the estrous cycle [14, 49]. Consistently, we detected mRNA
from all three endothelin isoforms and both receptors
using qPCR. The expression of Edn2, Edn3 and Ednrb
was, however, very low compared to Edn1 and Ednra, and
only Edn1 and Ednra were differently expressed after
exposure to progesterone. In the bovine oviduct, the ex-
pression of EDN1, EDNRA and EDNRB mRNA was high-
est during the peri-ovulatory period. During this period,
EDN1 also caused the highest increase in oviduct con-
traction. In bovine oviduct epithelial cells, EDN1 stimu-
























































































































































































Fig. 1 Progesterone-regulated gene expression in mouse fallopian tubes. Quantitative PCR analyses of 8 transcripts in mouse fallopian tubes treated
with ethanol (EtOH) 0.01 % (v/v) as control (C) or progesterone (P; 100 nmol/L) in vitro for 2 h or 8 h. The relative mRNA abundance in the figure is
presented as the normalized value (normalized to the housekeeping genes Hprt and Rpl19). Error bars represent standard error of mean. Significantly
different expression between control and exposed fallopian tubes at the two time points is indicated by * (p < 0.05), ** (p < 0.01) or *** (p < 0.001)
Fig. 2 Localization of the PGR in mouse fallopian tubes. Fallopian tubes from A, cycling, wild-type mice, and B; PGRLacZ mice samples were stained to
detect β-galactosidase activity and the location of PGR. Positive blue staining was observed in the epithelial and muscle cells of PGRLacZ (+/−) mice
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the oviduct has a major role in the control of local con-
tractions during the transport of gametes/embryos [14].
Our results indicate that the endothelin signalling is likely
regulated, in turn, by progesterone.
We are not aware of any previous studies of Ednra
regulation in the fallopian tube. Zhang et al. showed that
Ednra was up-regulated in different tissues after proges-
terone treatment as well as in pregnant mice [46]. We
found a down regulation of Ednra in the fallopian tube,
suggesting that progesterone might regulate Ednra-ex-
pression in different directions depending on the tissue.
When the controls for Ednra were compared, a decrease
in mRNA abundance between the 2 h and 8 h samples
was discovered. This decrease in abundance could either
be due to less transcription and/or decreased stability of
the mRNA.
In both the mouse and human fallopian tube, both iso-
forms of PGR are highly expressed [20]. In humans, the
expression seems to vary across the menstrual cycle and
differ between the different parts of the fallopian tube
[50]. In our study, Pgr mRNA was down-regulated by pro-
gesterone, which is consistent with results from an earlier
study showing that there was a time-dependent reduction
of PGRA and PGRB protein expression in immature mice
treated with a single dose of progesterone [21].
Ednra and Pgr were not markedly affected by the pro-
gesterone treatment as measured by the microarray ana-
lysis at 20 min or 2 h. However, with qPCR, significantly
lowered mRNA levels after progesterone treatment were
identified at both 2 h and 8 h in a separate experiment.
One reason for this apparent difference at 2 h could be
that both are receptors, and therefore, their expression is
low compared to many other types of mRNA. A micro-
array has a considerably higher detection limit than a
qPCR assay; thus, changes in genes that are hardly de-
tectable by a microarray are much more subjected to
noise than more highly expressed genes. A second rea-
son might be that a gene might only be present and reg-
ulated in a small subset of the cells analysed, making it
difficult to find small changes because they can drown in
the noise from other cells. A third explanation could
also be that the arrays were only performed with a repli-
cation of four per group, while the smaller amount of
RNA required for the qPCR allowed us to analyze 9 bio-
logical replicates per treatment group, providing much
higher statistical power.
A recent study investigated the differences in gene ex-
pression in fallopian tubes of mice completely lacking a
functional Pgr (PgrLacZ mice) and heterozygous mice
(PgrLacZ (+/−)) carrying one copy of the Pgr gene using
both microarray and qPCR [51]. However, the overlap of
the differentially expressed genes in that study and the
genes found to be regulated directly by progesterone inthe present study was small. Indeed, comparing the dif-
ference in gene expression between the two genotypes
will reveal differences that are also indirectly affected by
the lack of the receptor. Indeed, of the 9 genes investi-
gated by qPCR after stimulation of ovulation in imma-
ture mice by hCG (thus inducing a progesterone-surge),
6 genes differed before treatment between the two geno-
types. The authors identified an up-regulation of Edn3
in heterozygous mice 8 hours after hCG treatment, while
we did not observe any changes of Edn3 either at 2 or
8 h after progesterone treatment. This suggests that the
up-regulation of Edn3 found during induced ovulation
in the fallopian tube in the other study is not a direct ef-
fect of PGR activation.
Conclusions
To our best knowledge, this is the first study demon-
strating that Edn1 and Ednra are directly regulated by
progesterone in the mouse fallopian tube. We also con-
firm that PGR antagonists accelerate the transport of the
OCC through the fallopian tube. Our results further sup-
port that progesterone and PGR plays an essential role in
OCC transport that involves both non-genomic and gen-
omic mechanisms. It is important to reveal the mecha-
nisms and regulation of gamete transport in the fallopian
tube because it is an essential step in natural reproduction
and may contribute to a better understanding of the causes
of infertility in women and the development of new and
better contraceptives. To better understand the role of pro-
gesterone in the fallopian tube, studies on gene regulation
in vivo would be important to perform in the future.
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